adverse events following immunization
COVID-19, due process and an SNR problem
At a press conference streamed live on March 18, the head of the European Medicines Agency (EMA) announced that the body – which serves as the European Union’s drug and vaccine regulator – had concluded that the AstraZeneca COVID-19 vaccine was not associated with unusual blood clots that some vaccine recipients